Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cord blood-derived mesenchymal stromal cells
- Development stage
- Preclinical
- Lead developer
- CytoMed Therapeutics China
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intrathecal, Intraarticular, Intradiscal, Intranasal, Inhalation, Intraperitoneal, Intra-pancreatic, Intracoronary
01
Overview
LongevityBank's cord blood-derived mesenchymal stromal cells (MSCs) are a cell therapy candidate being explored for anti-aging interventions and the treatment of age-related degenerative diseases. These multipotent stem cells possess the ability to differentiate into multiple cell lineages and exert regenerative effects through the secretion of bioactive molecules that facilitate tissue repair and modulate immune responses. While LongevityBank primarily operates as a cell bank (offering UCB, MSC, PBMC, and iPSC banking), it identifies these MSCs as a key component of its research into regenerative medicine and longevity-focused therapies.
- Other names
- MSCsMesenchymal Stem Cellscord blood-derived MSCs
Beyond the preview
Go deeper on cord blood-derived mesenchymal stromal cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cord blood-derived mesenchymal stromal cells.